Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carci...
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Xanthine dehydrogenase (XDH) is a critical enzyme involved in the oxidative metabolism of purines, pterin and aldehydes and a central component of the innate immune system. However, the prognostic value of XDH in predicting tumor-infiltrating lymphocyte abundance, the immune response, and survival in different cancers, including hepatoce...
Alternative Titles
Full title
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_379762abd16649e68de6cd1a4908b36f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_379762abd16649e68de6cd1a4908b36f
Other Identifiers
ISSN
1475-2867
E-ISSN
1475-2867
DOI
10.1186/s12935-021-02173-7
